FDAnews
www.fdanews.com/articles/187763-revas-bioresorbable-scaffold-earns-ce-mark

Reva’s Bioresorbable Scaffold Earns CE Mark

July 26, 2018

Reva announced that its Motiv bioresorbable scaffold received a CE Mark for treating below-the-knee peripheral artery disease.

The device is made from a proprietary polymer designed specifically for use in vascular scaffolds.

The scaffold is used for patients experiencing critical limb ischemia, a severe artery blockage of the lower extremities, and is visible under x-ray for accurate placement in the artery.

View today's stories